IRVINE, Calif.--(BUSINESS WIRE)-- #biologics--Immunis, a clinical-stage biotech company developing a first-in-class multi-active biologic, announced the launch of its new logo and brand identity. The rebrand reflects the company’s scientific focus on multi-pathway biology and its mission to improve muscle function, metabolic health, and overall healthspan. Immunis’ platform is built on the understanding that age-related and chronic diseases are driven by interconnected biological pathways. Unlik